Lupin Announces FDA Approval of Supplemental New Drug Application for Solosec (secnidazole) for the Treatment of Trichomoniasis

BALTIMORE, July 1, 2021 /PRNewswire/ –Lupin Pharmaceuticals, Inc., the U.S. based wholly-owned subsidiary of global pharma major Lupin Limited (Lupin), announced today that the U.S. Food and Drug Administration (FDA) has approved the company’s supplemental New Drug Application (sNDA) to expand the use of Solosec (secnidazole) to include the treatment of trichomoniasis in adults. Trichomoniasis… Read More »

Providing Excellence: Removing a Complex Hernia with Robotic Surgery

Two surgeries in one day. Thanks to Mission Health’s commitment to bring world-class technology to the people of western North Carolina, 74-year-old Alice McLaughlin, a retired blanket mill worker who lives in Swannanoa and is the caregiver to her 47-year-old son who was paralyzed in a car accident, only spent one night recovering in the… Read More »